FR2883M - Médicament a base de 3',5'-phosphate cyclique d'adénosine. - Google Patents
Médicament a base de 3',5'-phosphate cyclique d'adénosine.Info
- Publication number
- FR2883M FR2883M FR935614A FR935614A FR2883M FR 2883 M FR2883 M FR 2883M FR 935614 A FR935614 A FR 935614A FR 935614 A FR935614 A FR 935614A FR 2883 M FR2883 M FR 2883M
- Authority
- FR
- France
- Prior art keywords
- product based
- medicinal product
- cyclic adenosine
- adenosine phosphate
- phosphate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
- C07H19/20—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Pharmacology & Pharmacy (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR935614A FR2883M (fr) | 1963-05-21 | 1963-05-21 | Médicament a base de 3',5'-phosphate cyclique d'adénosine. |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR935614A FR2883M (fr) | 1963-05-21 | 1963-05-21 | Médicament a base de 3',5'-phosphate cyclique d'adénosine. |
Publications (1)
Publication Number | Publication Date |
---|---|
FR2883M true FR2883M (fr) | 1964-11-02 |
Family
ID=8804378
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR935614A Expired FR2883M (fr) | 1963-05-21 | 1963-05-21 | Médicament a base de 3',5'-phosphate cyclique d'adénosine. |
Country Status (1)
Country | Link |
---|---|
FR (1) | FR2883M (fr) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2017731A1 (fr) * | 1968-09-10 | 1970-05-22 | Boehringer Mannheim Gmbh | |
NL7003222A (fr) * | 1969-04-30 | 1970-11-03 | ||
FR2206087A1 (en) * | 1972-11-13 | 1974-06-07 | Icn Pharmaceuticals | 9-beta-d-arabinofuranosyl-adenine 3',5'-cyclo monophosphate - - antiviral cpd,and its intermediates |
FR2213777A1 (en) * | 1973-01-16 | 1974-08-09 | Voorhees John | Nucleoside cyclic phosphate compsns. - for relieving skin proliferation diseases |
US3978213A (en) * | 1972-07-10 | 1976-08-31 | Nelson Research & Development Company | Cosmetic use of cyclic amp and phosphodiesterase inhibitors |
-
1963
- 1963-05-21 FR FR935614A patent/FR2883M/fr not_active Expired
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2017731A1 (fr) * | 1968-09-10 | 1970-05-22 | Boehringer Mannheim Gmbh | |
NL7003222A (fr) * | 1969-04-30 | 1970-11-03 | ||
US3978213A (en) * | 1972-07-10 | 1976-08-31 | Nelson Research & Development Company | Cosmetic use of cyclic amp and phosphodiesterase inhibitors |
FR2206087A1 (en) * | 1972-11-13 | 1974-06-07 | Icn Pharmaceuticals | 9-beta-d-arabinofuranosyl-adenine 3',5'-cyclo monophosphate - - antiviral cpd,and its intermediates |
FR2213777A1 (en) * | 1973-01-16 | 1974-08-09 | Voorhees John | Nucleoside cyclic phosphate compsns. - for relieving skin proliferation diseases |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FR3806M (fr) | Médicament a base d'un dérivé de la quinazolone-(4). | |
FR3769M (fr) | Médicament a base de dérivés d'imidazolidone. | |
FR3540M (fr) | Médicament a base de dérivés de la 7-hydroxy-2-oxo-1.2-dihydroquinoléine. | |
FR93909E (fr) | Procédé de préparation de benzoxazine-3,1 ones-2. | |
FR3111M (fr) | Médicament a base de dérivé de cystéine. | |
FR2887M (fr) | Médicament a base de dérivés de benzodiazépine. | |
FR2883M (fr) | Médicament a base de 3',5'-phosphate cyclique d'adénosine. | |
FR3455M (fr) | Médicament a base de nucléosides de fluoropyrimidines. | |
FR2424M (fr) | Médicament a base de dérivés d'uridine. | |
FR3807M (fr) | Médicament a base de dérivés de pipéridine. | |
FR3405M (fr) | Médicament a base d'une sulfométhyl-polymyxine. | |
NL151053B (nl) | Werkwijze voor de bereiding van cyclododecatrieen-(1,5,9). | |
FR3202M (fr) | Médicament a base de dérivé de théophylline. | |
FR3456M (fr) | Médicament a base de fluoropyrimidines. | |
NL150803B (nl) | Werkwijze voor het bereiden van een ribonycleoside -5'-monofosfaat. | |
FR2239M (fr) | Médicaments a base de dialcoyl-aminoalcoyl-pipéridines. | |
FR3294M (fr) | Médicament a base de dérivés de benzoxazépine. | |
FR3724M (fr) | Médicament a base d'anisoyl-3 hydroxy-4 p. méthoxy-phényl-6α-pyrone. | |
FR3323M (fr) | Médicament a base de dérivé de l'aza-thiaxanthene. | |
FR3478M (fr) | Médicament a base de dérivés de l'imidazole. | |
FR3878M (fr) | Médicament a base de dérivés de benzodiazépine. | |
FR3494M (fr) | Médicament a base de 16α-méthyl-stéroides. | |
FR3229M (fr) | Médicaments a base de éthynyl-17α méthyl-4 oestratriene-1,3,5(10) ol-17β. | |
FR3757M (fr) | Médicament a base de streptokinase. | |
FR3512M (fr) | Médicaments a base de 1-beta-d-arabinofuranosylcytosine. |